MedPath

A randomized study comparing effects of donepezil and galantamine in Alzheimer disease :attentional function of clinical trial

Not Applicable
Conditions
Alzhimer disease
Registration Number
JPRN-UMIN000012544
Lead Sponsor
Department of Neuropsychiatry, Keio University School of Medicine,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
26
Inclusion Criteria

Not provided

Exclusion Criteria

either previous history or now taking other choline inhibitors (galantamine, rivastigmine) and memantine, taking antipsychotic or antidepressant medication ,there was a previous history of mental llness or substance abuse,either an MRI or a CT scan had revealed focal brain lesions,routine blood tests (including evaluation of serum vitamin B12 and thyroid function) were abnormal findings , the patient has pacemaker, other findings in terms with the aims of this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath